Q1 2021 Holdings
Filed 2021-05-14 | 64 holdings | $112.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | ADR | 04351P101 | $67.3M | 521,923 | 59.7% |
| Align Technology Inc(ALGN) | COMM | 016255101 | $24.6M | 45,500 | 21.9% |
| Cytokinetics Inc(CYTK) | COMM | 23282W605 | $9.1M | 389,720 | 8.0% |
| Coherus BioSciences(CHRS) | COMM | 19249H103 | $6.3M | 434,555 | 5.6% |
| BioCryst Pharmaceuticals Inc(BCRX) | COMM | 09058V103 | $3.9M | 378,774 | 3.4% |
| Natera(NTRA) | COMM | 632307104 | $314.8K | 3,100,560 | 0.3% |
| Karuna Therapeutics, Inc. | COMM | 48576A100 | $234.7K | 1,952,441 | 0.2% |
| Bolt Biotherapeutics, Inc.(BOLT1EUR) | COMM | 097702104 | $90.6K | 2,754,437 | 0.1% |
| Y-mAbs Therapeutics, Inc(YMABUSD) | COMM | 984241109 | $66.4K | 2,194,278 | 0.1% |
| AstraZeneca PLC(AZN) | ADR | 046353108 | $51.5K | 1,035,732 | 0.0% |
| Health Care Select Sector SpdrPut | COMM | 81369Y959 | $46.7K | 400,000 | 0.0% |
| Checkmate Pharmaceuticals Inc | COMM | 162818108 | $43.8K | 3,606,707 | 0.0% |
| Jazz Pharmaceuticals PLC(JAZZ) | COMM | G50871105 | $42.1K | 255,928 | 0.0% |
| Inozyme Pharma, Inc. | COMM | 45790W108 | $40.2K | 2,028,308 | 0.0% |
| United Therapeutics Corp(UTHR) | COMM | 91307C102 | $36.0K | 215,054 | 0.0% |
| Eli Lilly and Co(LLY) | COMM | 532457108 | $33.7K | 180,501 | 0.0% |
| Nucana Biomed Ltd | ADR | 67022C106 | $27.9K | 5,599,999 | 0.0% |
| Merus N.V. | COMM | N5749R100 | $27.4K | 1,311,039 | 0.0% |
| Galera Therapeutics, Inc(GRTX) | COMM | 36338D108 | $27.2K | 3,083,712 | 0.0% |
| Nextcure, Inc | COMM | 65343E108 | $26.7K | 2,671,856 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COMM | 00434H108 | $24.2K | 178,538 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | COMM | 75615P103 | $23.8K | 238,520 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COMM | 60468T105 | $23.6K | 138,030 | 0.0% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COMM | 46116X101 | $22.2K | 655,001 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COMM | 69366J200 | $22.1K | 466,840 | 0.0% |
| Insmed Inc(INSM) | COMM | 457669307 | $21.1K | 618,950 | 0.0% |
| Akouos, Inc | COMM | 00973J101 | $21.0K | 1,515,074 | 0.0% |
| Gilead Sciences IncCall | COMM | 375558903 | $19.4K | 300,000 | 0.0% |
| Exelixis Inc(EXEL) | COMM | 30161Q104 | $19.0K | 839,181 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COMM | 74366E102 | $17.0K | 654,900 | 0.0% |
| ObsEva SA | COMM | H5861P103 | $15.4K | 4,749,623 | 0.0% |
| Uniqure NV(QURE) | COMM | N90064101 | $14.4K | 427,122 | 0.0% |
| Regenxbio Inc(RGNX) | COMM | 75901B107 | $12.3K | 361,735 | 0.0% |
| Horizon Therapeutics PLC | COMM | G46188101 | $12.3K | 133,997 | 0.0% |
| Nucana Biomed Ltd | Ordinary Shares | GB00BYWYV | $12.0K | 2,400,000 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COMM | 92532F100 | $9.8K | 45,700 | 0.0% |
| Dexcom Inc(DXCM) | COMM | 252131107 | $9.7K | 27,000 | 0.0% |
| Amgen Inc(AMGN) | COMM | 031162100 | $9.7K | 38,868 | 0.0% |
| Agenus Inc(AGENEUR) | COMM | 00847G705 | $9.5K | 3,478,201 | 0.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COMM | 604749101 | $9.4K | 476,401 | 0.0% |
| Athira Pharma, Inc. | COMM | 04746L104 | $9.4K | 509,168 | 0.0% |
| ChemoCentryx Inc(CCXIEUR) | COMM | 16383L106 | $9.2K | 179,999 | 0.0% |
| ChemoCentryx IncPut | COMM | 16383L956 | $7.7K | 150,000 | 0.0% |
| Tcr2 Therapeutics Inc | COMM | 87808K106 | $7.4K | 336,682 | 0.0% |
| Amarin Corp | ADR | 023111206 | $7.3K | 1,170,584 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COMM | 87164F105 | $6.7K | 298,644 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COMM | 040047607 | $6.3K | 91,448 | 0.0% |
| Marinus Pharmaceuticals Inc(MRNS*) | COMM | 56854Q200 | $5.7K | 370,351 | 0.0% |
| Jounce Therapeutics Inc(JNCEEUR) | COMM | 481116101 | $5.3K | 511,822 | 0.0% |
| Insulet Corp(PODD) | COMM | 45784P101 | $4.6K | 17,500 | 0.0% |